NeuroSense Therapeutics Ltd (NASDAQ:NRSN) has a beta value of 1.25 and has seen 68470.0 shares traded in the last trading session. The company, currently valued
In the last trading session, 83164.0 shares of the NeuroSense Therapeutics Ltd (NASDAQ:NRSN) were traded, and its beta was 1.28. Most recently the company’s share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
